Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer

被引:64
|
作者
Berry, Donna L. [1 ,2 ]
Wang, Qian [3 ]
Halpenny, Barbara [1 ]
Hong, Fangxin [3 ,4 ]
机构
[1] Dana Farber Canc Inst, Phyllis F Cantor Ctr Res Nursing & Patient Care S, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[3] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Prostate cancer; Randomized trial; Internet; Decision making; QUALITY-OF-LIFE; VALIDATION; CHOICE; AID;
D O I
10.1016/j.pec.2012.04.002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To describe relationships between use of the Personal Patient Profile-Prostate (P3P) decision support system and patient characteristics, and perceived preparation for decision making (PrepDM), satisfaction and decisional regret in the context of prostate cancer treatment choice. Methods: 494 men with localized prostate cancer (LPC) were randomized to receive the P3P intervention or usual care and completed pre-treatment, 1-month and 6-month outcome measures. Multivariable linear regression models were fit for each outcome. Results: Physician consult visits prior to enrollment, race/ethnicity, and use of clinic-provided books were significant predictors of perceived PrepDM at 1 month. Prior Internet use and PrepDM significantly predicted 6-month decision satisfaction. Decisional regret was significantly predicted by demographics, anxiety, PrepDM score, and EPIC bowel domain score at 6 months. Use of P3P did not predict any outcome. Conclusion: While the P3P intervention did not significantly affect the outcomes, pre-enrollment information and preparation were strong predictors of the 1- and 6-month outcomes. Decision regret was significantly influenced by personal characteristics and post-treatment symptoms/side effects. Practice implications: Information received and used between biopsy and the treatment options consult visit is likely to make a difference in decision satisfaction. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:262 / 267
页数:6
相关论文
共 50 条
  • [31] Colorectal Cancer Screening Among Men With Newly Diagnosed Prostate Cancer
    Leachman, Brooke K.
    Scharf, Lawrence J.
    Sobczak, Mark L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E7 - E7
  • [32] The Association Between Financial Toxicity and Treatment Regret in Men With Localized Prostate Cancer
    Joyce, Daniel D.
    Wallis, Christopher J. D.
    Huang, Li-Ching
    Hoffman, Karen E.
    Zhao, Zhiguo
    Koyama, Tatsuki
    Goodman, Michael
    Hamilton, Ann S.
    Wu, Xiao-Cheng
    Paddock, Lisa E.
    Stroup, Antoinette
    Cooperberg, Matthew R.
    Hashibe, Mia
    O'Neil, Brock B.
    Kaplan, Sherrie H.
    Greenfield, Sheldon
    Penson, David F.
    Barocas, Daniel A.
    JNCI CANCER SPECTRUM, 2022, 6 (06)
  • [33] PROVIDER INTERACTIONS WITH PARTNERS OF MEN NEWLY DIAGNOSED WITH PROSTATE CANCER
    Zeliadt, Steven
    Penson, David F.
    Moinpour, Arol M.
    Blough, David K.
    Fedorenko, Catherine R.
    Hall, Ingrid J.
    Smith, Judith Lee
    Ekwueme, Donatus
    Thompson, Ian M.
    Keane, Thomas E.
    Ramsey, Scott D.
    ANNALS OF BEHAVIORAL MEDICINE, 2010, 39 : 5 - 5
  • [34] ASSOCIATION BETWEEN FINANCIAL BURDEN AND TREATMENT REGRET IN MEN WITH LOCALIZED PROSTATE CANCER
    Joyce, Daniel D.
    Wallis, Christopher J. D.
    Huang, Li-Ching
    Hoffman, Karen E.
    Zhao, Zhiguo
    Koyama, Tatsuki
    Conwill, Ralph
    Penson, David F.
    Barocas, Daniel A.
    JOURNAL OF UROLOGY, 2022, 207 (05): : E422 - E422
  • [35] Multidisciplinary Therapy in Men with Newly Diagnosed Oligometastatic Prostate Cancer
    Watanabe, Kazuhiro
    Kawaguchi, Gen
    Ikeda, Yohei
    Hara, Noboru
    Nishiyama, Tsutomu
    RESEARCH AND REPORTS IN UROLOGY, 2021, 13 : 565 - 571
  • [36] THE PREVALENCE OF SOLID MALIGNANCIES IN MEN NEWLY DIAGNOSED WITH PROSTATE CANCER
    Teper, Ervin
    Colon, Ivan
    Blank, William
    Weiss, Jeffrey P.
    Macchia, Richard J.
    Karanikolas, Nicholas T.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 4 - 4
  • [37] When study site contributes to outcomes in a multi-center randomized trial: a secondary analysis of decisional conflict in men with localized prostate cancer
    Meghan L Underhill
    Fangxin Hong
    Donna L Berry
    Health and Quality of Life Outcomes, 12
  • [38] When study site contributes to outcomes in a multi-center randomized trial: a secondary analysis of decisional conflict in men with localized prostate cancer
    Underhill, Meghan L.
    Hong, Fangxin
    Berry, Donna L.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2014, 12
  • [39] Multi-center randomized controlled trial on a decision aid for localized prostate cancer in referral hospitals in West-Coast Peninsular Malaysia
    Jalil, N. B.
    Lee, P. Y.
    Ong, T. A.
    Zulkefli, N. A. B. M.
    Razack, A. H.
    Malek, R.
    Sundram, M.
    Omar, S.
    Sathiyananthan, J. R.
    Kumar, P.
    BJU INTERNATIONAL, 2015, 116 : 17 - 17
  • [40] Treatment decision making in a population-based sample of black and white men with localized prostate cancer
    Reamer, Elyse
    Yang, Felix
    Xu, Jinping
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (03)